| | Cancer | Chemotherapy
Tuberculosis Chemoprophylaxis: Preventing Active TB in High-Risk Groups
TB chemoprophylaxis (preventive therapy) uses antibiotics to halt progression from latent TB infection (LTBI) to active disease.
Standard Regimens
- Isoniazid (INH) 9 months (daily/biweekly) – gold standard.
- INH + Rifapentine weekly × 12 weeks (3HP) – shorter, higher completion.
- Rifampin 4 months (4R) – alternative if INH intolerant.
Indications
- Close contact with infectious TB case
- LTBI + HIV, diabetes, CKD, TNF-α inhibitors, transplant, silicosis
- Children <5 with LTBI
- Pregnant women with recent exposure
Monitoring
- Monthly symptom review, LFTs (baseline + periodic if risk factors).
- Adherence counseling critical.
Prevents individual disease and community transmission.
Chemotherapy - Related Articles
- PICC Lines vs. CVADs: Understanding Central Vein Access
- THC & Cancer: Current Evidence on Antitumor Effects
- Intrathecal Chemotherapy: Direct CNS Delivery for Leukemia, Lymphoma, and Brain Metastases
- Effective Anti-Nausea Strategies for Chemotherapy Patients
- CytopathCV: Open-Source Deep Learning Platform for Cytology Image Analysis
- Understanding Chemotherapy: Preparation and What to Expect
- Actinomycin-D (Dactinomycin): Side Effects, Uses & Precautions
